首页|期刊导航|中国比较医学杂志|麝香通心滴丸通过调控NRF2/GPX4通路抑制铁死亡改善动脉粥样硬化

麝香通心滴丸通过调控NRF2/GPX4通路抑制铁死亡改善动脉粥样硬化OA

Shexiang Tongxin Dropping Pills alleviate atherosclerosis by inhibiting ferroptosis via regulating the NRF2/GPX4 pathway

中文摘要英文摘要

目的 麝香通心滴丸是治疗动脉粥样硬化(AS)的常用药物,本研究旨在探讨麝香通心滴丸治疗AS的作用机制.方法 使用ApoE-/-小鼠联合高脂饮食复制AS动物模型,分为空白组、模型组、阳性药(PC)组、麝香通心滴丸低/中/高剂量(STDP-L/M/H)组.通过检测小鼠血清中TC、TG、LDL-C及HDL-C水平,以及观察主动脉组织油红O染色,验证麝香通心滴丸对AS小鼠的治疗作用;通过生化试剂盒检测主动脉中SOD、GSH-Px活性和MDA水平,观察麝香通心滴丸对AS小鼠氧化应激的影响;通过ELISA试剂盒检测主动脉中IL-6、IL-1β和TNF-α表达水平,观察麝香通心滴丸对AS小鼠炎症的影响;通过RT-qPCR和Western blot检测铁死亡以及NRF2/GPX4通路相关蛋白的表达水平,观察麝香通心滴丸对AS小鼠铁死亡和NRF2/GPX4通路的影响.结果 麝香通心滴丸可降低AS小鼠的血清TC、TG、LDL-C水平(P<0.01),升高HDL-C水平(P<0.01),减轻主动脉斑块沉积,增加小鼠主动脉中SOD、GSH-Px的活性(P<0.01),降低MDA水平(P<0.05),降低IL-6、IL-1β和TNF-α水平(P<0.01).同时,麝香通心滴丸可调节铁死亡相关蛋白(FTL、Transferrin、Steap3)的表达(P<0.05,P<0.01),调节 NRF2/GPX4 通路相关蛋白(NRF2、GPX4、HO-1、ACSL4)的表达(P<0.05,P<0.01).结论 本研究证明麝香通心滴丸可通过调控NRF2/GPX4通路,抑制铁死亡,从而抑制氧化应激与炎症反应,改善动脉粥样硬化.

Objective Shexiang Tongxin Dropping Pills is a commonly used drug for the treatment of atherosclerosis(AS).This study aims to investigate the mechanism of Shexiang Tongxin Dropping Pills in the treatment of AS.Methods In this study,ApoE-/-mice were subjected to high-fat feeding to establish AS models.The AS models were randomized into the Control group,Model group,positive drug(PC)group,and low/medium/high-dose Shexiang Tongxin Dropping Pills(STDP-L/M/H)groups.The therapeutic effect of Shexiang Tongxin Dropping Pills on AS mice was verified by detecting the serum profiles of total cholesterol(TC),triglyceride(TG),low-density lipoprotein cholesterol(LDL-C),and high-density lipoprotein cholesterol(HDL-C),as well as by observing oil red O staining of aortic tissues.The effects of Shexiang Tongxin Dropping Pills on oxidative stress in AS mice were assessed by measuring aortic superoxide dismutase(SOD),glutathione peroxidase(GSH-Px)activities,and malondialdehyde(MDA)levels with commercial biochemical kits.The effect on inflammation in AS mice was assessed by detecting the expression levels of interleukin-6(IL-6),interleukin-1 β(IL-1 β),and tumor necrosis factor-α(TNF-α)in the aorta via ELISA kits.Additionally,the effects on ferroptosis and the NRF2/GPX4 pathway in AS mice were investigated by detecting the expression levels of related proteins using RT-qPCR and Western blot.Results The result showed that Shexiang Tongxin Dropping Pills reduced the serum levels of TC,TG,and LDL-C(P<0.01),increased the serum level of HDL-C(P<0.01),alleviated aortic plaque deposition,enhanced the activities of SOD and GSH-Px in the aorta(P<0.01),decreased the MDA level(P<0.05),and lowered the levels of IL-6,IL-1β,and TNF-α in AS mice(P<0.01).Meanwhile,Shexiang Tongxin Dropping Pills regulated the expression of ferroptosis-related proteins(FTL,Transferrin,Steap3,P<0.05,P<0.01)and proteins associated with the NRF2/GPX4 pathway(NRF2,GPX4,HO-1,ACSL4,P<0.05,P<0.01).Conclusions This study demonstrates that Shexiang Tongxin Dropping Pills can improve atherosclerosis by regulating the NRF2/GPX4 pathway,inhibiting ferroptosis,and suppressing oxidative stress and inflammatory responses.

庄锐;吕迪阳;纪越;尤良震;李乐;高群;高鑫;马立永;潘熠

北京中医药大学东直门医院,北京 100007北京中医药大学东直门医院,北京 100007北京中医药大学东直门医院重点实验室,北京 100007北京中医药大学东直门医院重点实验室,北京 100007北京中医药大学东直门医院,北京 100007北京中医药大学东直门医院,北京 100007北京中医药大学东直门医院,北京 100007北京中医药大学东直门医院,北京 100007北京中医药大学东直门医院,北京 100007

医药卫生

ApoE-/-小鼠麝香通心滴丸动脉粥样硬化铁死亡氧化应激炎症NRF2/GPX4通路

ApoE-/-mouseShexiang Tongxin Dropping Pillsatherosclerosisferroptosisoxidative stressinflammationNRF2/GPX4 pathway

《中国比较医学杂志》 2026 (11)

1-10,10

吴阶平医学基金会临床科研专项(320.6750.2022-25-7)国家自然科学基金青年科学基金(82405313)第76批博士后面上项目(2024M760287)北京中医药大学东直门医院青年骨干人才培养计划项目(DZMG-QNGG003).

10.3969/j.issn.1671-7856.2026.11.001

评论